13F

HCSG HEALTHCARE SERVICES GROUP

2026Q1 · CUSIP 421906108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
258
Δ holders QoQ
+8
Breadth percentile
Top 34%
Whale holders
134
Δ whales
+3
Inst. holding value
$1.3B
New positions
41
Closed positions
33
Price momentum (1Q)
+2.9%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+10 · h=313 2018Q2: Δ-6 · h=307 2018Q3: Δ-18 · h=289 2018Q4: Δ+9 · h=298 2019Q1: Δ-4 · h=294 2019Q2: Δ-19 · h=275 2019Q3: Δ-30 · h=245 2019Q4: Δ-1 · h=244 2020Q1: Δ-4 · h=240 2020Q2: Δ+17 · h=257 2020Q3: Δ-15 · h=242 2020Q4: Δ-7 · h=235 2021Q1: Δ+14 · h=249 2021Q2: Δ+7 · h=256 2021Q3: Δ-19 · h=237 2021Q4: Δ-14 · h=223 2022Q1: Δ-10 · h=213 2022Q2: Δ+0 · h=213 2022Q3: Δ+0 · h=213 2022Q4: Δ-10 · h=203 2023Q1: Δ+12 · h=215 2023Q2: Δ-11 · h=204 2023Q3: Δ+3 · h=207 2023Q4: Δ-9 · h=198 2024Q1: Δ+17 · h=215 2024Q2: Δ-13 · h=202 2024Q3: Δ+1 · h=203 2024Q4: Δ-1 · h=202 2025Q1: Δ+4 · h=206 2025Q2: Δ+17 · h=223 2025Q3: Δ+2 · h=225 2025Q4: Δ+25 · h=250 2026Q1: Δ+8 · h=258 2018Q1: holders=313 2018Q2: holders=307 2018Q3: holders=289 2018Q4: holders=298 2019Q1: holders=294 2019Q2: holders=275 2019Q3: holders=245 2019Q4: holders=244 2020Q1: holders=240 2020Q2: holders=257 2020Q3: holders=242 2020Q4: holders=235 2021Q1: holders=249 2021Q2: holders=256 2021Q3: holders=237 2021Q4: holders=223 2022Q1: holders=213 2022Q2: holders=213 2022Q3: holders=213 2022Q4: holders=203 2023Q1: holders=215 2023Q2: holders=204 2023Q3: holders=207 2023Q4: holders=198 2024Q1: holders=215 2024Q2: holders=202 2024Q3: holders=203 2024Q4: holders=202 2025Q1: holders=206 2025Q2: holders=223 2025Q3: holders=225 2025Q4: holders=250 2026Q1: holders=258 -30 -15 +0 +15 +30 178254329 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 18% +13.3% +32.5%
2024Q1 Top 18% -6.9% +0.0%
2023Q1 Top 14% -15.7% -30.8%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
25.3
EPS (TTM)
$0.95
EPS YoY
+72.7%
Revenue (TTM)
$1.9B
Revenue YoY
+6.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $425M 2022-09-30: $414M 2022-12-31: $424M 2023-03-31: $417M 2023-06-30: $419M 2023-09-30: $411M 2023-12-31: $424M 2024-03-31: $423M 2024-06-30: $426M 2024-09-30: $428M 2024-12-31: $438M 2025-03-31: $448M 2025-06-30: $458M 2025-09-30: $464M 2025-12-31: $467M 2026-03-31: $463M 2022-06-30: EPS 0.09 2022-09-30: EPS 0.00 2022-12-31: EPS 0.22 2023-03-31: EPS 0.16 2023-06-30: EPS 0.11 2023-09-30: EPS -0.07 2023-12-31: EPS 0.32 2024-03-31: EPS 0.21 2024-06-30: EPS -0.02 2024-09-30: EPS 0.19 2024-12-31: EPS 0.15 2025-03-31: EPS 0.23 2025-06-30: EPS -0.44 2025-09-30: EPS 0.59 2025-12-31: EPS 0.43 2026-03-31: EPS 0.37 0M 233M 467M $M -0.48 0.08 0.65 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 24 2023-03-31: PE 31.32023-06-30: PE 25.52023-09-30: PE 24.12023-12-31: PE 23.42024-03-31: PE 20.22024-06-30: PE 24.32024-09-30: PE 16.52024-12-31: PE 20.52025-03-31: PE 26.92025-06-30: PE 115.52025-09-30: PE 32.72025-12-31: PE 26.72026-03-31: PE 22.4 15 68 121 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)